A comparison between New Zealand and Australia’s approach to biotech shows we're doing a lot of things right, but that government support for the sector in New Zealand could be improved. New Zealand biotech leaders say that if a comprehensive government .
It s urgent - NZ biotech s call to Government voxy.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from voxy.co.nz Daily Mail and Mail on Sunday newspapers.
Global competition for Pfizer puts pressure on TGA AstraZeneca approval26/01/2021|3min
Global competition for the Pfizer-BionTech vaccine will place increasing pressure on the TGA to approve the AstraZeneca vaccine which is set to be produced in Australia.
Australia is scheduled to receive 80,000 doses of the Pfizer-BionTech vaccine in late-February.
However, there are significant problems with the Pfizer supply chain into Europe with delays putting Australian Biotechnology company CSL in the spotlight as the chosen producer of a domestic treatment.
The Morrison government paid a premium and predict production could be ramped up to one million doses per week.
Prime Minister Scott Morrison reinforced the importance of a vaccine made on domestic soil to ensure Australia’s rollout is not “completely hostage” to the production schedules of countries made overseas